Estimates of cancer incidence in China for 2000 and projections for 2005

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 1, 2005, Pages 243-250

  Yang, Ling ^a   Parkin, D Maxwell ^b   Ferlay, Jacques ^b   Li, Liandi ^a   Chen, Yude ^c  

^a Natl Off Cancer Prev and Contr   (China)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CHILD; CHINA; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; LUNG CANCER; MALE; POPULATION GROWTH; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; FORECASTING; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; POISSON DISTRIBUTION; POPULATION SURVEILLANCE; REGISTRIES; RISK FACTORS;

EID: 12844277985     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Yang L, Parkin DM, Li LD, Chen YD. Time trends in cancer mortality in China: 1987-1999. Int J Cancer 2003;106:771-83.
2. Yang L, Parkin DM, Li LD, Chen YD, Bray FI. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Brit J Cancer 2004;90:2157-66.
3. WHO. National cancer control programmes: policies and managerial guidelines. Second version. Geneva, Switzerland: WHO; 2002.
4. Jensen OM, Parkin DM, MacLennan R, Muir CS, Dkeet RG. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon, France: IARC Press; 1991.
5. Yang L, Parkin DM, Whelan S, et al. Statistics on cancer in China: Cancer registration in 2002. Eur. J Cancer Prev. 14 In press 2005.
6. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer in Five Continents, Vol. VIII. IARC Scientific Publication No. 155. Lyon, France: IARC Press; 2002.
7. Li LD, Lu FZ, Zhang SW, et al. Analysis of cancer mortality and distribution in China from year 1990 through 1992. An epidemiologic study. Chin J Oncol 1996;18:403-7.
8. Yang L, Parkin DM, Li LD, Chen YD. Sources of information on the burden of cancer in China. Asian Pacific J Cancer Prev 2003;4:23-30.
9. Ferlay J, Bray F, Sankila R, Parkin DM. EUCAN: Cancer incidence, mortality and prevalence in the European Union 1995, version 2.0. IARC Cancer Base No. 4. Lyon, IARC Press; 1999.
10. Jensen OM, Estève J, Møller H, Renard H. Cancer in the European community and its member states. Eur J Cancer 1990;26:1167-256.
11. Francis B, Green M, Payne C, Eds. The GLIM System. Release 4 Manual. Oxford, UK: Clarendon Press; 1993.
12. WHO. International Classification of Disease and Related Health Problems: Tenth Revision. Geneva, Switzerland: WHO; 1993.
13. Population Census Office under the State Council and Department of Population, Social, Science and Technology Statistics, National Bureau of Statistic of China. Tabulation on the 2000 Population Census of the People's Republic of China. Beijing: National Statistical Publishing House; 2002.
14. United Nations, Population Division. World Population Prospects: The 2002 Revision. Population Database. http://esa.un.org/unpp/index.asp?panel=1, New York (NY), USA: United Nations; 2003.
15. Engeland A, Haldorsen T, Tretli S, et al. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. Acta Pathol Microbiol Scand 1993;101:1-124.
16. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancer Base No. 5. Lyon, France: IARC Press; 2001.
17. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Vol. VII IARC Scientific Publications No. 143, Lyon, France: IARC Press; 1997.
18. Yang L, Parkin DM, Li LD, Chen YD. A comparison of the sources of cancer mortality in China. Cancer Causes Control. 2004;15:681-7.
19. Verdecchia A, Mariotto A, Capocaccia R, et al. Incidence and prevalence of all cancerous diseases in Italy: trends and implications. Eur J Cancer 2001;37:1149-57.
20. European Network of Cancer Registries (ENCR). EUROCIM version 4.0. European Incidence Database V2.3. Lyon, France: IARC Press; 2001.
21. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
22. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 cancers in 1990. Int J Cancer 1999;80:827-41.
23. Dyba T, Hakulinen T. Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med 2000;19:1941-52.
24. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997;33:1075-107.
25. Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco hazards in China. 1. Retrospective proportional mortality study of one million deaths. Brit Med J 1998;317:1411-22.
26. Clinical Trial Service Unit (CTSU). Emerging Tobacco Hazards in China. http://rum.ctsu.ox.ac.uk/tobacco. Oxford, UK: Oxford University Press; 1998.
27. IARC. IARC Monographs on Tobacco Smoke and Involuntary Smoking (Vol. 83). Lyon, France: IARC Press; 2002.
28. Pisani P, Parkin DM, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997;6:387-400.
29. Ministry of Health P.R. China. http://www.moh.gov.cn/was40/. Beijing, China: Ministry of Health; 2001.
30. WHO - Immunization, Vaccines and Biologicals. http://www.who.int/ vaccines-diseases/diseases/hepatitis_b.shtml. Geneva, Switzerland: WHO; 2002.
31. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-9.
32. Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002;94:1445-57.
33. Ji BT, Chow WH, Yang G, et al. Dietary habits and stomach cancer in Shanghai, China. Int J Cancer 1998;76:659-64.
34. Guo W, Blot WJ, Li JY, et al. A nested case-control study of oesophageal and stomach cancers in the Linxian nutrition intervention trial. Int J Epidemiol 1994;23:444-50.
35. Cai L, Zheng ZL, Zhang ZF. Risk factors for the gastric cardia cancer: a case-control study in Fujian Province. World J Gastroenterol 2003;9:214-8.
36. Limburg P, Qiao Y, Mark S, et al. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 2001;93:226-33.
37. Wang RT, Wang T, Chen K, et al. Helicobacter pylori infection and gastric cancer: evidence from a retrospective cohort study and nested case-control study in China. World J Gastroenterol 2002;8:1103-7.
38. Wong BC, Lam SK, Wong WM, et al; China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;14;291:187-94.
39. Ji BT, Chow WH, Yang G, et al. The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer 1996;77:2449-57.
40. Setiawan VW, Zhang ZF, Yu GP, et al. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer 2001;92:600-4.
41. Wu AH, Yang D, Pike MC. A meta-analysis of soyfoods and risk of stomach cancer: the problem of potential confounders. Cancer Epidemiol Biomarkers Prev 2000;9:1051-8.
42. Mahady GB, Pendland SL, Yun GS, Lu ZZ, Stoia A. Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer Res 2003;23:3699-702.
43. Editorial Committee for the Atlas of Cancer Mortality. Atlas of cancer mortality in the People's Republic of China. Beijing, China: China Map Press;1979.
44. Dong ZW, Tang PZ, Li LD, Wang GQ. The strategy for esophageal cancer control in high-risk areas of China. Jpn J Clin Oncol 2002;32:S10-2.
45. Qiao YL, Hou J, Yang L, et al. The trends and preventive strategies of esophageal cancer in high-risk areas of Taihang Mountains China. Acta Acad Med Sin 2001;23:10-4.
46. Blot WJ, Li JY, Taylor PR, et al. The Linxian trials: mortality rates by vitamin-mineral intervention group. Am J Clin Nutr 1995;62:1424s-6.
47. Yokokawa Y, Ohta S, Hou J, et al. Ecological study on the risks of esophageal cancer in Ci-Xian, China: the importance of nutritional status and the use of well water. Int J Cancer 1999;83:620-4.
48. Liu SF, Shen Q, Dawsey SM, et al. Esophageal balloon cytology and subsequent risk of esophageal and gastric-cardia cancer in a high-risk Chinese population. Int J Cancer 1994;57:775-80.
49. Dawsey SM, Fleischer DE, Wang GQ, et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 1998;83:220-31.